These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9458373)

  • 1. Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas.
    Garcia S; Martini F; De Micco C; Andrac L; Hardwigsen J; Sappa P; Lavaut MN; Le Treut YP; Charpin C
    Int J Oncol; 1998 Feb; 12(2):443-7. PubMed ID: 9458373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of E-cadherin expression in hepatocellular carcinoma].
    Garcia S; Martini F; De Micco C; Andrac L; Sappa P; Hardwigsen J; Lavaut MN; Le Treut YP; Charpin C
    Ann Pathol; 1998 Apr; 18(2):98-102. PubMed ID: 9608861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
    Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
    Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
    Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas.
    Ihara A; Koizumi H; Hashizume R; Uchikoshi T
    Hepatology; 1996 Jun; 23(6):1441-7. PubMed ID: 8675162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
    Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
    Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
    Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
    Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas.
    Nuruki K; Toyoyama H; Ueno S; Hamanoue M; Tanabe G; Aikou T; Ozawa M
    Oncol Rep; 1998; 5(5):1109-14. PubMed ID: 9683818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
    Zhao XJ; Li H; Chen H; Liu YX; Zhang LH; Liu SX; Feng QL
    World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
    Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
    World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.
    Zhang ZY; Wu YQ; Zhang WG; Tian Z; Cao J
    Chin J Dent Res; 2000 Nov; 3(3):36-9. PubMed ID: 11314533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin and beta-catenin expression in breast medullary carcinomas.
    Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
    Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
    Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
    Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.